Showing results (1051-1060 of 1,273) with videos related to

Sort By:
Pageof 128
Leukemia & Lymphoma|April 23, 2004
Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphomaJennifer R Brown, Guylaine Gaudet, Jonathan W Friedberg, et al.
Elife|July 9, 2019
Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cellsBen F Brian, Adrienne S Jolicoeur, Candace R Guerrero, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitorsDamien M Rasmussen, Manny M Semonis, Joseph T Greene, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGADAdnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Journal of Neurology|July 16, 2013
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid usePaul W O'Connor, Fred D Lublin, Jerry S Wolinsky, et al.
The Lancet. Neurology|December 8, 2011
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trialGiancarlo Comi, Nicola De Stefano, Mark S Freedman, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinomaA P Kudelka, A Hasenburg, C F Verschraegen, et al.
Anticancer Research|August 6, 2000
Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in IsraelJ Iscovich, A Fischbein, J Fisher-Fischbein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2022
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionNoam Barda, Michal Canetti, Mayan Gilboa, et al.
Pageof 128